These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 12071094
1. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2000--II. Gram-negative bacteria]. Suzuki Y, Nishinari C, Endo H, Tamura C, Jinbo K, Hiramatsu N, Akiyama K, Koyama T. Jpn J Antibiot; 2002 Apr; 55(2):154-80. PubMed ID: 12071094 [Abstract] [Full Text] [Related]
2. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--II. Gram-negative bacteria]. Suzuki Y, Nishinari C, Endo H, Hiramatsu N, Akiyama K, Koyama T. Jpn J Antibiot; 2003 Aug; 56(4):309-35. PubMed ID: 14567255 [Abstract] [Full Text] [Related]
6. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2000--I. Gram-positive bacteria]. Suzuki Y, Nishinari C, Endo H, Tamura C, Jinbo K, Hiramatsu N, Akiyama K, Koyama T. Jpn J Antibiot; 2002 Apr; 55(2):139-53. PubMed ID: 12071093 [Abstract] [Full Text] [Related]
7. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria]. Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T. Jpn J Antibiot; 2002 Feb; 55(1):1-21. PubMed ID: 11977919 [Abstract] [Full Text] [Related]
8. [Antibacterial activities of monobactams against fresh clinical isolates]. Deguchi K, Yokota N, Koguchi M, Nakane Y, Fukayama S, Nishimura Y, Oda S, Tanaka S, Kato M, Sato K. Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297 [Abstract] [Full Text] [Related]
12. [Susceptibilities of clinical bacterial isolates to antimicrobial agents. A study mainly focused on imipenem. Reported by the Research Group for Testing Imipenem Susceptibility on Clinical Isolates]. Igari J. Jpn J Antibiot; 1990 Nov; 43(11):1956-2002. PubMed ID: 2287060 [Abstract] [Full Text] [Related]
14. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution]. Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Takanashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Kosakai N, Yamaguchi K, Matsumoto T, Kashitani F, Tanaka M. Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353 [Abstract] [Full Text] [Related]
15. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution]. Kumamoto Y, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Kitagawa R, Igari J, Oguri T, Kosakai N, Yamaguchi K, Kashitani F, Yonezu S, Yamanaka Y, Takaha M, Iori F. Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862 [Abstract] [Full Text] [Related]
16. [Susceptibilities of clinical isolates to antibacterial agents. A study mainly focused on ofloxacin (the second report). Reported by the Research Group for Testing ofloxacin Susceptibility on Clinical Isolates]. Kosakai N. Jpn J Antibiot; 1989 May; 42(5):1125-65. PubMed ID: 2664255 [Abstract] [Full Text] [Related]
17. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2002). I. Susceptibility distribution]. Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Hirose T, Yamaguti O, Ishibashi K, Shigeta S, Suzutani T, Yoshida H, Imafuku Y, Murai M, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Sato S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Furuya N, Deguchi T, Ishihara S, Ooe H, Nishikawa M, Oka T, Kitamura M, Fukuhara Y, Kamidono S, Arakawa S, Kumon H, Monden K, Matsumoto T, Takahashi K, Naito S, Egashira T, Kohno S, Miyazaki Y, Hirakata Y, Aoki S. Jpn J Antibiot; 2004 Jun; 57(3):246-74. PubMed ID: 15376785 [Abstract] [Full Text] [Related]
18. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004)]. Goto H, Takeda H, Kawai S, Watanabe T, Okazaki M, Shimada K, Nakano K, Yokouchi H, Ikemoto H, Mori T, Igari J, Oguri T, Yamamoto M, Inoue H, Nakadate T, Suwabe A, Ashino Y, Gejyo F, Okada M, Aoki N, Kitamura N, Suzuki Y, Karasawa Y, Kudo K, Kobayashi N, Tanaka T, Sumitomo M, Matsushima T, Oka M, Niki Y, Suga M, Tosaka M, Kohno S, Hirakata Y, Kondou A, Matsuda J, Nakano M, Nasu M, Hiramatsu K, Oikawa S. Jpn J Antibiot; 2006 Oct; 59(5):323-54. PubMed ID: 17180803 [Abstract] [Full Text] [Related]
19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution]. Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Hirose T, Shigeta S, Yamaguti O, Ishibashi K, Suzutani T, Yoshida H, Imafuku Y, Murai M, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Sato S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Furuya N, Deguchi T, Ishihara S, Ooe H, Oka T, Kitamura M, Fukuhara Y, Kamidono S, Arakawa S, Kumon H, Monden K, Matsumoto T, Muratani T, Naito S, Egashira T, Konishi T, Kohno S, Hirakata Y, Kondo A, Matsuda J, Nakano M. Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404 [Abstract] [Full Text] [Related]
20. [Susceptibilities of clinical bacterial isolates to antimicrobial agents. A study mainly focused on imipenem. Research Group for Testing Imipenem Susceptibility on Clinical Isolates]. Igari J. Jpn J Antibiot; 1990 Oct; 43(10):1723-82. PubMed ID: 2086814 [Abstract] [Full Text] [Related] Page: [Next] [New Search]